Testimonials

THE TESTIMONIALS OF OUR CUSTOMERS TESTIFY OF IDDI’S ADDED VALUE OF A HIGHLY SKILLED SERVICES OFFERING FOR CLINICAL RESEARCH.

Fast EDC Database Go-Live

Testimonials

Fast EDC Database Go-LiveFast EDC Database Go-Live: Well done!

Lots of hard work went in to this, and the timelines were ambitious – great job!

Clare Price, Director, Clinical Development, Ophthea

EDC Go-Live in Short Timelines

Testimonials

EDC go-live: A superb effort indeed to get this done in short timelines!

Thank you for being flexible in the way you have been, this has given us a great result so we are ready to start the study!

 

 

Zubair Hussain VP Regulatory & Clinical Affairs, iSTAR Medical

Flexibility to IDMC Request

Testimonials

IDDI staff was quite flexible to IDMC requests. They were adept at pointing out risks that AZ had inadvertently overlooked, and would always offer solutions to mitigate the risks. The planning and actual meeting with the IDMC was hitch-free. IDDI staff was always very professional, and I would rate them 5 on a scale of 1 – 5. My interaction with IDDI staff have been through e-mails and teleconferences. They were prompt in calling into meetings, and responding to e-mails. Ugochi A Emeribe, Principal Statistician, Astrazeneca R&D, Wilmington, DE, USA

Time Effective Clinical Trials

Testimonials

Time effective clinical trialsTime effective clinical trials: We really appreciate the work you (and the rest of the team behind the scenes) have done to make this possible. The fact that the system went live in approximately 40 days from finalized protocol has not been lost on me.  This is a truly amazing feat!’ and ‘Well done, IDDI team!  You are now officially PanOptimists together with us! Paul G. Chaney, President and CEO, PanOptica, Inc. , Bernardsville, NJ, USA

Meeting ambitious timelines

Testimonials

We are truly grateful to all those who participated in this important study, said Jim Taylor, CEO of Oraya Therapeutics. Our partnership with IDDI was of great benefit, particularly with respect to their responsiveness, their commitment to quality and precision, and their ability to meet our very ambitious timelines. Jim Taylor, CEO Oraya Therapeutics, Newark, CA, USA